References: Lentine KL, Smith JM, Hart A, et al. OPTN/SRTR 2020 Annual Data Report: kidney. Am J Transplant. 2022;22:21-136. S2.
Sarkar M, Bramham K, Mortiz MK, Coscia L. Reproductive health in women following abdominal organ transplant. Am J Transplant. 2018;18:1068-1076.
Chandra A, Midvedt K, Asbert A, Eide IA. Immunosuppression and reproductive health after kidney transplantation. Transplantation. 2019;103:e325-e333.
Szpotansk-Sikorska M, Mazanowska N, Madej A, Kociszewska-Najman B, Wieglos M, Pietrzak B. Reproductive life planning in women after kidney or liver transplantation. Clin Transplant. 2018;32(9):e13378.
van Buren MC, Beck DK, Lely AT, van der Wetering J, Massey EK. EXPloring attitudes and factors influencing reproductive choices in kidney transplant patients (The EXPECT-study). Clin Transplant. 2021;35:e14473.
Shah S, Venkatesan RL, Gupta A, et al. Pregnancy outcomes in women with kidney transplant: metaanalysis and systematic review. BMC Nephrol. 2019;20:24.
Moritz MJ, Constantinescu S, Coscia LA, et al. Transplant Pregnancy Registry International (TPRI) 2020 Annual Report. Gift of Life Institute.
Deshpande NA, James NT, Kucirka LM, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transplant. 2012;18:621-629.
D'Souza R, Soete E, Silversides CK, et al. Pregnancy outcomes following cardiac transplantation. J Obstet Gynaecol Can. 2018;40(5):566-571.
Shaner J, Coscia LA, Constantinescu S, et al. Pregnancy after lung transplant. Prog Transplant. 2012;22(2):134-140.
Cabiddu G, Spotti D, Gernone G, et al. A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology. J Nephrol. 2018;31:665-681.
Hoeltzenbein M, Elefant E, Vial T, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A. 2012;158A:588-596.
Mortiz MJ, Constantinescu S, Coscia LA, Armenti D. Mycophenolate and pregnancy: teratology principles and national transplantation pregnancy registry experience. Am J Transplant. 2017;17:581-582.
The Mycophenolate Risk Evaluation and Mitigation Strategy Program. Accessed 8/12/2022. https://www.mycophenolaterems.com/#Main.
US Medical Eligibility Criteria for Contraceptive Use. Accessed 4/19/22. https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html.
McKay DB, Josephson MA, Armenti VT, et al. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005;5:1592-1599.
Ritchie J, Seidman D, Srisengfa Y, Perito ER, Sarkar M. Family planning in liver transplant: patient and provider knowledge and practices. Liver Transplant. 2020;26:1233-1240.
French VA, Davis JS, Sayles HS, Wu SS. Contraception and fertility awareness among women with solid organ transplants. Obstet Gynecol. 2013;122(4):809-814.
Shah S, Christianson AL, Bumb S, Verma P. Contraceptive use among women with kidney transplants in the United States. J Nephrol. 2022;35:629-638.
Rafie S, Lai S, Barcia JE, Mody SK. Contraceptive use in female recipients of a solid-organ transplant. Prog Transplant. 2014;24(4):344-348.
DeFilippis EM, Haythe J, Farr MA, Kobashigawa J, Kittleson MM. Practice patterns surrounding pregnancy after heart transplantation. Circ Heart Fail. 2020;13:e006811.
Ross LF. Ethical considerations related to pregnancy in transplant recipients. N Engl J Med. 2006;354:1313-1316.
No Comments.